Health Populi

APRIL 27, 2021

people who are part of Native and Pacific Islander, American Indian and Alaska Native, Hispanic and Latinx, and Black (non-Hispanic) communities were more likely to have had a COVID-19 diagnosis in the first fourteen months of the pandemic than people were White or Asian citizens. of Hispanic and LatinX people (19% of U.S.

COVID-19 163

COVID-19 COVID-19 Vaccine Public Health Health Insurance 163

Health Populi

AUGUST 24, 2021

In the 19th and 20th centuries, segregated black hospitals were emblematic of separate but unequal health care,” begins the editorial introducing an entire issue of JAMA dedicated to racial and ethnic disparities and inequities in medicine and health care, published August 17, 2021. than on white people.

COVID-19 139

COVID-19 Health Care Inequity COVID-19 Vaccine Medicare 139

Bill of Health

FEBRUARY 28, 2022

And, though vaccines are effective in reducing the likelihood of severe outcomes and death, data shows that this protection is not perfect — for example, in the first week of December 2021, nearly a quarter of COVID-19 deaths occurred in “fully” vaccinated people ( 682 of 2,912 deaths ). .

COVID-19 364

COVID-19 COVID-19 Vaccine Bioethics Public Health 364

Health Populi

MAY 20, 2021

You’re stressed, I’m stressed; most of us have felt stress in the COVID-19 era which began in the U.S. Nearly eighteen months later, a 2021 Edelman Trust Barometer update finds that consumers’ trust in the health care industry is under stress, too — in the U.S. in the first quarter of 2020.

COVID-19 127

COVID-19 COVID-19 Vaccine Health Insurance Medicare 127

Health Populi

JANUARY 14, 2021

where trust in every type of organization and expert has plummeted in the wake of the COVID-19 pandemic, political and social strife, and an economic downturn. Edelman then connects the dots between information hygiene and vaccine hesitancy in this chart. The info hygiene-vaccine gap in the U.S.

COVID-19 79

COVID-19 COVID-19 Vaccine Governance Public Health 79

Health Populi

JANUARY 5, 2021

2: Moderna, funded with nearly $1 billion in taxpayer dollars to develop a COVID-19 vaccine, sets the highest prevailing market price for the product. The controversy here is that this was the highest price set although the company received 100% of the development costs for the vaccine covered by the U.S. government. .”

COVID-19 62

COVID-19 COVID-19 Vaccine Public Health Doctors 62

Bill of Health

JANUARY 7, 2022

Over the summer of 2021, concern grew that the vaccines were not providing the near-perfect protection against symptomatic disease and transmission that had first emboldened the administration to jettison other public health measures. The entire pandemic response hinged on vaccination as a silver bullet. By Justin Feldman.

Public Health 340

Public Health FDA Governance COVID-19 Vaccine 340